Springer Nature acquires British Journal of Cancer
The academic publisher acquires full ownership of BJC enhancing its international growth and development
London | May 13, 2021
Springer Nature has today acquired full ownership of the prestigious British Journal of Cancer (BJC).
Launched in 1947 (1) as a general oncology journal, BJC publishes across the full spectrum of cancer research, covering molecular cell biology, genetics, translational research, clinical studies and epidemiology. Since the 1980s it has been published in partnership with Springer Nature (2).
Along with its nearly 75 years of heritage and association with CRUK, the acquisition of BJC to full ownership by Springer Nature marks an important step in the journal’s development and growth. Now as part of the wider Springer Nature oncology portfolio and medical titles, the journal will benefit from enhanced international reach, author services and international collaboration, further cementing its status as a key journal for the cancer community.
Speaking of the acquisition Alison Mitchell, Chief Journals Officer, Springer Nature,
“The research published in the British Journal of Cancer provides the medical community with a vital global platform for key discussions, engagement and development in the field of oncology. Springer Nature has and continues to develop a strong programme of journals representing leading researchers, practitioners and societies in medicine. We have had a strong partnership with CRUK for many years and this move to full ownership for Springer Nature gives us an opportunity to build on BJC's strong reputation and engagement within the community, and to grow and develop the journal to continue to meet the needs of its authors and readers.”
As part of this acquisition, the strong relationship between CRUK and Springer Nature will still continue. The CRUK name will still be used in relation to the journal, and the journal will continue to be published with a by-line indicating this affiliation. BJC remains a key journal for CRUK’s outreach to its research community.
The journal homepage and additional information regarding submission and outreach can be found here.
###
1. BJC was the official journal of the British Empire Cancer Campaign which then evolved to become the Imperial Cancer Research Fund and then to Cancer Research UK.
2. It was originally published under the Macmillan Press Scientific & Medical Imprint and then Stockton Press. With the merger in 2015, it is now published under the Springer Nature brand.
Springer Nature advances discovery by publishing robust and insightful research, supporting the development of new areas of knowledge, making ideas and information accessible around the world, and leading the way on open access. Key to this is our ability to provide the best possible service to the whole research community: helping authors to share their discoveries; enabling researchers to find, access and understand the work of others; supporting librarians and institutions with innovations in technology and data; and providing quality publishing support to societies.
As a research publisher, Springer Nature is home to trusted brands including Springer, Nature Portfolio, BMC, Palgrave Macmillan and Scientific American. Springer Nature is also a leading educational and professional publisher, providing quality content through a range of innovative platforms, products and services. Every day, around the globe, our imprints, books, journals and resources reach millions of people. For more information, please visit springernature.com and @SpringerNature.
